Stock Track | Twist Bioscience Plummets 5.20% as JP Morgan Slashes Price Target

Stock Track

May 07, 2025

Twist Bioscience Corp (TWST) saw its stock price plummet by 5.20% in Tuesday's trading session, following a significant price target cut by JP Morgan analysts.

The sharp decline came after JP Morgan lowered its price target for Twist Bioscience from $40 to $33, maintaining an "Underweight" rating on the stock. This reduction in the price target suggests that the investment bank has become more pessimistic about the company's near-term prospects, which likely triggered a sell-off among investors.

While JP Morgan's downgrade seems to be the primary driver of the stock's decline, it's worth noting that Guggenheim maintained its price target for Twist Bioscience at $50 per share. This conflicting view from another analyst firm highlights the divergent opinions on the company's future performance. Investors appear to be giving more weight to JP Morgan's bearish stance in the short term, as reflected in the significant stock price drop.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1143931069"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143931069\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143931069?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 00:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143931069","market":"us","top_or_hot":-1,"title":"Stock Track | Twist Bioscience Plummets 5.20% as JP Morgan Slashes Price Target","media":"Stock Track","content":"<p>Twist Bioscience Corp (TWST) saw its stock price plummet by 5.20% in Tuesday's trading session, following a significant price target cut by JP Morgan analysts.</p>\n\n<p>The sharp decline came after JP Morgan lowered its price target for Twist Bioscience from $40 to $33, maintaining an \"Underweight\" rating on the stock. This reduction in the price target suggests that the investment bank has become more pessimistic about the company's near-term prospects, which likely triggered a sell-off among investors.</p>\n\n<p>While JP Morgan's downgrade seems to be the primary driver of the stock's decline, it's worth noting that Guggenheim maintained its price target for Twist Bioscience at $50 per share. This conflicting view from another analyst firm highlights the divergent opinions on the company's future performance. Investors appear to be giving more weight to JP Morgan's bearish stance in the short term, as reflected in the significant stock price drop.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Twist Bioscience Plummets 5.20% as JP Morgan Slashes Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Twist Bioscience Plummets 5.20% as JP Morgan Slashes Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-07 00:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Twist Bioscience Corp (TWST) saw its stock price plummet by 5.20% in Tuesday's trading session, following a significant price target cut by JP Morgan analysts.</p>\n\n<p>The sharp decline came after JP Morgan lowered its price target for Twist Bioscience from $40 to $33, maintaining an \"Underweight\" rating on the stock. This reduction in the price target suggests that the investment bank has become more pessimistic about the company's near-term prospects, which likely triggered a sell-off among investors.</p>\n\n<p>While JP Morgan's downgrade seems to be the primary driver of the stock's decline, it's worth noting that Guggenheim maintained its price target for Twist Bioscience at $50 per share. This conflicting view from another analyst firm highlights the divergent opinions on the company's future performance. Investors appear to be giving more weight to JP Morgan's bearish stance in the short term, as reflected in the significant stock price drop.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1143931069","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143931069","pubTimestamp":1746550411,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Twist Bioscience Corp  saw its stock price plummet by 5.20% in Tuesday's trading session, following a significant price target cut by JP Morgan analysts.The sharp decline came after JP Morgan lowered its price target for Twist Bioscience from $40 to $33, maintaining an \"Underweight\" rating on the stock. This reduction in the price target suggests that the investment bank has become more pessimistic about the company's near-term prospects, which likely triggered a sell-off among investors.While J","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"摩根大通下调目标价，Twist Bioscience股价暴跌5.20%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"Twist Bioscience Corp (TWST) saw its stock price plummet by 5.20% in Tuesday's trading session, following a significant price target cut by JP Morgan analysts.\nThe sharp decline came after JP Morgan lowered its price target for Twist Bioscience from $40 to $33, maintaining an \"Underweight\" rating on the stock. This reduction in the price target suggests that the investment bank has become more pessimistic about the company's near-term prospects, which likely triggered a sell-off among investors.\nWhile JP Morgan's downgrade seems to be the primary driver of the stock's decline, it's worth noting that Guggenheim maintained its price target for Twist Bioscience at $50 per share. This conflicting view from another analyst firm highlights the divergent opinions on the company's future performance. Investors appear to be giving more weight to JP Morgan's bearish stance in the short term, as reflected in the significant stock price drop.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}